Zobrazeno 1 - 10 of 1 922 pro vyhledávání: '"Ardid, D"'
1
Akademický článek
Antihyperalgesic properties of gut microbiota: Parabacteroides distasonis as a new probiotic strategy to alleviate chronic abdominal pain.
Autor: Gervason S; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Meleine M; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Lolignier S; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Meynier M; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France.; M2iSH, UMR 1071 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Daugey V; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Birer A; M2iSH, UMR 1071 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France.; Centre National de Référence de la Résisitance aux Antibiotiques, Service de Bactériologie, Clermont-Ferrand, France., Aissouni Y; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Berthon JY; GREENTECH SA, Saint-Beauzire, France., Ardid D; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Filaire E; ECREIN Team, Human Nutrition Unit (UNH), UMR 1019 INRAE-UCA, University of Clermont-Auvergne, Clermont-Ferrand, France., Carvalho FA; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France.
Publikováno v: Pain [Pain] 2024 May 01; Vol. 165 (5), pp. e39-e54. Date of Electronic Publication: 2023 Sep 27.
Zobrazit plný text záznamu
3
Akademický článek
Tyrosine kinase type A-specific signalling pathways are critical for mechanical allodynia development and bone alterations in a mouse model of rheumatoid arthritis.
Autor: Delay L; Université Clermont Auvergne, Inserm U1107 NEURO-DOL, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France.; Department of Anesthesiology, University California San Diego, San Diego, CA, United States., Barbier J; Université Clermont Auvergne, Inserm U1107 NEURO-DOL, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France., Aissouni Y; Université Clermont Auvergne, Inserm U1107 NEURO-DOL, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France., Jurczak A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Boudieu L; Université Clermont Auvergne, Inserm U1107 NEURO-DOL, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France., Briat A; UMR 1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Clermont-Ferrand, France., Auzeloux P; UMR 1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Clermont-Ferrand, France., Barrachina C; MGX, Biocampus Montpellier, CNRS, INSERM, Université Montpellier, Montpellier, France., Dubois E; MGX, Biocampus Montpellier, CNRS, INSERM, Université Montpellier, Montpellier, France., Ardid D; Université Clermont Auvergne, Inserm U1107 NEURO-DOL, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France., Miot-Noirault E; UMR 1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Clermont-Ferrand, France., Svensson CI; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Moqrich A; Aix-Marseille Universitè, CNRS, Institut de Biologie du Dèveloppement de Marseille, UMR 7288, Case 907, 13288 Marseille, Cedex 09, France., Marchand F; Université Clermont Auvergne, Inserm U1107 NEURO-DOL, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France.
Publikováno v: Pain [Pain] 2022 Jul 01; Vol. 163 (7), pp. e837-e849. Date of Electronic Publication: 2021 Sep 23.
Zobrazit plný text záznamu
4
Akademický článek
Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice.
Autor: Meynier M; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France.; M2iSH, UMR 1071 INSERM, UMR1382 INRAé, University of Clermont Auvergne, Clermont-Ferrand, France., Daugey V; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Mallaret G; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Gervason S; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Meleine M; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Barbier J; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Aissouni Y; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Lolignier S; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., Bonnet M; M2iSH, UMR 1071 INSERM, UMR1382 INRAé, University of Clermont Auvergne, Clermont-Ferrand, France., Ardid D; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France., De Vos WM; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; The Akkermansia Company™, Mont-Saint-Guibert, Belgium., Van Hul M; Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI), UCLouvain, Université Catholique de Louvain, Brussels, Belgium.; WELBIO-Walloon Excellence in Life Sciences and Biotechnology, WELBIO department, WEL Research Institute, Wavre, Belgium., Suenaert P; The Akkermansia Company™, Mont-Saint-Guibert, Belgium., Brochot A; The Akkermansia Company™, Mont-Saint-Guibert, Belgium., Cani PD; Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI), UCLouvain, Université Catholique de Louvain, Brussels, Belgium.; WELBIO-Walloon Excellence in Life Sciences and Biotechnology, WELBIO department, WEL Research Institute, Wavre, Belgium.; Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium., Carvalho FA; NeuroDol, UMR 1107 INSERM, University of Clermont Auvergne, Clermont-Ferrand, France.
Publikováno v: Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2298026. Date of Electronic Publication: 2024 Jan 03.
Zobrazit plný text záznamu
5
Akademický článek
Prevalence of chronic pain in opioid-maintained patients using the capture-recapture method: a nationwide population-based study.
Autor: Delorme J; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France.; Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France., Bertin C; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France.; Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France., Delage N; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France., Eschalier A; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France.; Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France.; Institut Analgesia, Faculté de Médecine, BP38, Clermont-Ferrand, France., Ardid D; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France., Authier N; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France.; Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France.; Institut Analgesia, Faculté de Médecine, BP38, Clermont-Ferrand, France., Chenaf C; Université Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol, Service de Pharmacologie Médicale, Centres Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Clermont-Ferrand, France.; Observatoire Français des Médicaments Antalgiques (OFMA)/French Monitoring Centre for Analgesic Drugs, Université Clermont Auvergne-CHU Clermont-Ferrand, F-63001 Clermont-Ferrand, France.
Publikováno v: Pain [Pain] 2021 Jan; Vol. 162 (1), pp. 195-202.
Zobrazit plný text záznamu
7
Akademický článek
Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation.
Autor: Mallaret G; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Lashermes A; Department of Microbiology, Université Paris-Saclay, National Research Institute for Agriculture, Food and the Environment, AgroParisTech, Micalis Institute, Jouy-en-Josas 78350, France., Meleine M; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Boudieu L; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Barbier J; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Aissouni Y; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Gelot A; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Chassaing B; Team 'Mucosal Microbiota in Chronic Inflammatory Diseases', INSERM U1016, CNRS UMR 8104, Université Paris Cité, Paris 75014, France., Gewirtz AT; Center for Inflammation, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA30033, United States., Ardid D; Department of Pharmacology, UMR 1107 NeuroDol, University of Clermont Auvergne, Clermont-Ferrand 63000, France., Carvalho FA; Department of Pharmacology, INSERM 1107 NeuroDOL/University of Clermont Auvergne, Clermont-Ferrand 63000, France. frederic.carvalho@inserm.fr.
Publikováno v: World journal of gastroenterology [World J Gastroenterol] 2022 Aug 07; Vol. 28 (29), pp. 3903-3916.
Zobrazit plný text záznamu
9
Akademický článek
Analysis of ultrasonic vocalisation does not allow chronic pain to be evaluated in rats
Autor: Jourdan, D, Ardid, D, Eschalier, A
Publikováno v: In Pain 2002 95(1):165-173
Zobrazit plný text záznamu
10
Akademický článek
Impact of the Microbiota on Pain.
Autor: Gervason, S., Defaye, M., Ardid, D., Berthon, J.-Y., Altier, C., Filaire, E., Carvalho, F. A.
Publikováno v: Douleur et Analgésie; jui2021, Vol. 34 Issue 2, p86-96, 11p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje